19 February 2026

Biologics Clinical research Psoriasis

Adalimumab proves durable in practice

19 February 2026

Biologics Clinical research Psoriasis

GLP-1/biologics combo delivers double win in PsA

5 February 2026

Biologics Rheumatoid Arthritis

Abatacept delays rheumatoid arthritis onset

11 December 2025

Biologics DMARDS Pharmaceuticals

DMARD routine bloods loosen

27 November 2025

Biologics Clinical research Psoriasis

Treat-to-target trumps therapy choice in PsA

27 November 2025

Biologics Psoriasis

Routine antibiotics linked to earlier biologic drop-off

30 October 2025

ACR Biologics

Proteomic analysis reveals how sex differences shape PsA

18 September 2025

Biologics Lupus

Anifrolumab moves closer to self-administration

18 September 2025

Biologics

Biologics trigger unexpected hair loss

24 July 2025

Biologics Rheumatology

Secukinumab falls short in GCA trial

10 July 2025

Biologics Cancer Rheumatoid Arthritis

ORAL Surveillance cancer signal replicated in observational data

12 June 2025

Biologics EULAR Psoriatic Athritis

Early biologic intervention yields lasting benefit in PsA

3 April 2025

Biologics Rheumatoid Arthritis

JAKi gets tick for RA second-line therapy

3 April 2025

Biologics Research

Combination targeted therapies are safe – mostly

3 April 2025

Anti JAKS Sjogren Syndrom

Tofacitinib promising for Sjögren’s Disease

6 February 2025

Interstitial Lung Disease Rheumatoid Arthritis TNF

TNF inhibitors safe in RA-associated ILD